6.8 Financial Investigations and Provider Review (FIPR)
6.8 Defining the Issues: Fraud, Waste, Abuse, and Material Misrepresentation (FWAM)
6.8 Techniques Used for Investigation
6.8 Retroactive Denials and Overpayments
6.8 Post-Payment Dispute Resolution Process – Appeals and External Reviews
6.8 Independent Review Organization (IRO)
6.8 Highmark Medical Review Committee (PA Only)
The mission of Highmark’s Financial Investigations and Provider Review (FIPR) department is twofold:
In addition to conducting post-payment practice pattern reviews, FIPR also investigates potential member and provider FWAM. Highmark’s FIPR unit takes a proactive approach to detecting and investigating potential health care FWAM. When necessary, FIPR carries out internal and/or external corrective action regarding fraudulent activity that impacts Highmark, its customers, or members.
For more information on FIPR, please visit highmark.com. Click on Fraud Prevention in the blue area at the bottom of the page.
Highmark established a fraud hotline so that members and providers can notify FIPR of potential fraud. The fraud hotline is automated and allows anyone to leave a message.
If you suspect fraud, contact your local FIPR department within Highmark:
Fraud is defined by state and federal laws and typically occurs when a provider or consumer intentionally submits, or causes someone else to submit, false or misleading information to a health insurance company for the purpose of receiving payments that an individual or entity is not eligible to receive.
Example: Billing for services not rendered.
Waste is defined as the overutilization of professional medical services or the misuse of resources by a health care provider.
Example: A provider’s belief is that all patients should receive an X-ray every time they have an appointment.
Abuse is defined as incidents or practices of providers, physicians, or suppliers of services and equipment that are inconsistent with accepted sound medical, business, or fiscal practices.
Example: Billing separate services that should be bundled under one service code.
When a provider submits claims to Highmark for reimbursement, the provider is contractually obligated to ensure that the information in the claim accurately reflects the services performed as documented in the provider’s records. Claims that do not accurately reflect the services performed are misrepresentations; when a misrepresentation results in an overpayment to the provider, it is a material misrepresentation.
Because the provider is contractually obligated to submit claims that accurately reflect the services performed, Highmark may retroactively adjust payments to reflect the services actually performed following a review of the provider’s records or receipt of other information that indicates a claim materially misrepresents the services performed. Highmark may retroactively adjust payments in these circumstances and seek recoupment even where there is no evidence that the provider or entity intentionally submitted claims containing misrepresentations.
Example: Coding claims to reflect that a more complicated, higher level office visit was performed when a lower office visit code was more appropriate.
Note: These four definitions are not mutually exclusive and may overlap. For example, billing unbundled services that should be bundled under one service code may be both abuse and a misrepresentation or even fraud.
Payment review1 is a key element of the screening process Highmark uses to assure that members receive health care services that are medically necessary and that the claims for these services are submitted properly. This process also ensures that claims are being paid in accordance with provider agreements, while at the same time addressing the integrity of the payment calculated by Highmark.
Highmark initiated payment review in 1962 in cooperation with the Pennsylvania Insurance Department. Since that time, it has increased in importance not only at Highmark but in the entire health care industry.
Payment reviews are now conducted in all Highmark service areas due to regulations established by Federal and State regulatory agencies, such as the Centers for Medicare & Medicaid Services (CMS), Federal Employee Program, and the respective State insurance departments. In addition, the national Blue Cross and Blue Shield Association (BCBSA) and the contracts we have with our group clients also require Highmark to monitor provider claims billing.
The ultimate goals of payment review are to:
In rare instances of suspected fraud, Highmark’s Financial Investigations and Provider Review (FIPR) tracks claim reporting to collect information that may become evidence for law enforcement officials or the courts. Professional physician consultants support and advise Highmark personnel in pre- and post-payment review activities.
1Unless otherwise specifically noted, when used in this Manual the term “payment review” is meant to also refer to the following processes, including but not limited to: provider audit/review, audit, claim(s) audit/review, post-payment audit/review, retroactive post-payment audit/review, coding audit/review, E/M audit/review, pre- payment audit review, post-payment practice pattern review, and pre-payment practice pattern review.
Highmark is required to monitor all providers in our participating, preferred, and managed care networks throughout Delaware, New York, Pennsylvania, and West Virginia. The claims being reviewed are for Highmark members and also for when Highmark is acting as the intermediary for contracted pricing for other Blue Cross and Blue Shield Plan members.
Highmark’s FIPR team is comprised of experienced health care professionals with expertise in clinical, financial, revenue cycle, health information management, and coding specializations. These individuals include nurses, financial and IT analysts, investigators, medical coders, consultants, and auditors.
Due to the complexity of facility billing and payment methodologies, Highmark also uses external firms to assist in payment reviews of paid claims. These reviews are conducted to ensure that providers are complying with industry standards on appropriate billing and that payments are monitored for accuracy.
Professional consultants are also engaged to support and advise Highmark personnel in the identification of problematic billing and coding issues.
For purposes of this Chapter and unless otherwise noted, if a section refers to “FIPR,” it is also referring to external firms and professional consultants that may assist or support Highmark’s payment review processes.
When a potential FWAM problem is identified, what actions are taken to correct the provider’s reporting?
In the payment review process, Highmark employs various techniques to investigate potential issues of fraud, waste, abuse, and material misrepresentation (“FWAM”).
Financial Investigations and Provider Review (FIPR) staff routinely surveys a percentage of all claims it receives. FIPR staff verifies the accuracy of claims by gathering information from hospital medical records departments, professional provider offices, or members.
FIPR utilizes an internal system to investigate unusual utilization. Highmark developed this web-based application to gain faster access to claims data and also to enhance reporting capabilities. The system is able to generate both summary and detailed reports from seven years of available data.
The reporting capabilities of the system allow for comparison of a provider’s utilization to the utilization of other providers within the same geographic region and specialty. This type of comparison allows FIPR to analyze utilization quickly and effectively, and it is these analyses that identify overutilization and potential fraudulent behavior.
FIPR employs predictive analytic software to search for and screen potentially aberrant claims. This software works by identifying patterns of suspicious behavior and provides a score based on that claim’s degree of risk; the higher the score, the higher the fraud risk. Claims identified by this process are then reviewed for accuracy and appropriateness of payment and, if necessary, FIPR will open an investigation of the specific claim or the provider.
Highmark continually updates the FWAM detection tools based on improvements in technology and data analysis techniques.
FIPR frequently conducts special studies to identify new areas for review and to assess the adequacy of our present claims systems to ensure cost-effective quality health care for our members.
FIPR continues to closely monitor claims after the claims have been paid in order to determine the appropriateness of the services reported. This involves long-term trending and monitoring of many services.
Health care organizations subject to Section 6032 of the federal Deficit Reduction Act of 2005 (the "DRA") are required to educate their providers and contractors about the False Claims Act as well as the organization's policies and programs for detecting and preventing fraud, waste, and abuse. The following documents are intended to satisfy Highmark Blue Cross Blue Shield of Western New York and Highmark Blue Shield of Northeastern New York's obligations under the DRA.
We know you share Blue Cross Blue Shield's goal of ensuring that all clinical and business activities are conducted in full compliance with applicable laws and government program requirements. Accordingly, we look forward to your cooperation in applying Blue Cross Blue Shield's fraud prevention and detection policies and programs in connection with the services you provide to our members.
If you have any questions regarding these documents, please do not hesitate to contact Blue Cross Blue Shield's fraud prevention program at 716-887-8451 or 800-333-8451.
Fraud Waste and Abuse Laws in Health Care:
When a potential problem is identified, a case investigation is initiated. Claims data is generated and reviewed.
Analysis of claims processed: A statistical analysis of the claims processed for a particular provider will be conducted. This analysis will compare all phases of a provider’s billing patterns to those of his or her peers.
Financial Investigations and Provider Review (FIPR) may select specific claims for a detailed review and also may select a statistical sample of claims. If a statistical sampling approach is used, FIPR would randomly select a population of claims and extrapolate the results over all the claims paid to a provider for a given period.
If irregularities are found during the investigation (for example, the provider is performing more of one particular service than his or her peers), FIPR will notify the provider of the potential irregularity and request a response.
On-site review: If warranted, an on-site review may be conducted. This usually includes obtaining copies of clinical records.
Patient interviews: Patients may also be interviewed to verify that services were performed as reported. If the patient’s age or condition precludes an interview, the investigator(s) may interview the patient’s relatives, as appropriate. These interviews may be necessary in all types of investigations conducted by FIPR. FIPR investigators are trained to avoid making improper comments about the provider or the quality or appropriateness of treatment the member received.
Discrepancies between information reported on the claim form and the member’s recollection of the services performed are pursued carefully. FIPR investigators make every effort to assess the reliability of persons interviewed and the accuracy of their statements. Whenever possible, all interviews are recorded to memorialize the details of any statements made. The recording will protect the member as well as the investigator(s) from misinterpreted information, avoiding the change of specific details at a later time, and potentially provide evidence for use in all proceedings. (Warnings of audio recording are given to the interviewees to avoid potential wiretap violations.)
FIPR informs the provider of the final results of the case investigation if a change in behavior or a refund appears to be appropriate.
It is the responsibility of FIPR investigators to examine and summarize hospital and office records and reports of on-site reviews. They also review statistical information on payments made and compare claim coding to Highmark medical and payment policies.
Although not required in every case, a professional consultant may be used to review documentation and provide a written opinion. The professional consultant program involves over 250 independent health care professionals who provide their perspective on issues of medical policy, clinical guidelines, and unusual claims.
A professional consultant is contracted as a Business Associate of Highmark. The consultants are typically actively practicing health care professionals, representing major professional specialties and disciplines. The consultants are required to:
Referrals to consultants involve two separate and distinct types of reviews: pre-payment and post-payment. Pre-payment investigations are performed on the medical necessity or appropriateness of a service(s) or procedure code(s) prior to claims payment. Post-payment investigations involve utilizing professional consultants to review overall practice patterns and specific claims as necessary.
In these situations, the consultants are generally providing their opinion as to whether the documentation in the medical records supported the services billed and the level of care. If there is a lack of supportive documentation, the consultants advise what services, or level of care, should have been reported.
In order to assure the credibility of these reviews, every effort is made to use a consultant of the same specialty or subspecialty and similar practice. A consultant from a different geographic location is typically used in an attempt to ensure that the provider being reviewed receives a completely unbiased review. Additionally, the consultants are currently in active practice to assure they are aware of the latest developments in their specialties.
Following review, the provider may be contacted by a FIPR representative to discuss several items such as: the statistical data; the individual treatment patterns; the professional consultant’s opinion; education on future reporting; and, if necessary, obtain a refund of overpaid monies.
This section summarizes how Financial Investigations and Provider Review (FIPR) staff conducts post-payment reviews of claim submissions and processing for potential fraud, waste, abuse, and material misrepresentation (FWAM).
FIPR staff periodically performs post-payment reviews of providers who have been selected based on their utilization and billing patterns, relative to their peers. Providers and members may also be selected for review based on various other criteria including, but not limited to, potential allegations of wrongdoing, systemic billing errors, and Fraud Hotline tips.
A statistically random sample of records for the questioned services is reviewed. Typically, a certified professional coder and/or registered nurse perform the reviews. However, qualified external consultants may on occasion be contracted to perform such reviews on behalf of Highmark.
Similarly, FIPR staff may on occasion pend and review a provider or member’s claim on a pre-payment basis.
In the performance of E/M (evaluation and management) reviews (whether pre- or post-payment), the reviewer will use the following criteria to assess adequacy of documentation to support the level of service billed:
FIPR reviewers document determinations of both over coding and under coding. In the event a FIPR reviewer determines that documentation supports a higher level code than billed, the reviewer gives credit for the underpayment.
At the conclusion of a payment review, the results are submitted in writing to the provider via certified mail, and facsimile if applicable. The provider is afforded the opportunity to rebut review findings by providing clarification and/or supporting documentation within 30 calendar days.
For providers in West Virginia responding to the receipt of a retroactive denial, please refer to the Prompt Pay Act “provider recovery process” located below.
Copies of review worksheets may be made available to the provider upon written request. Additionally, the provider may request a meeting with FIPR staff to:
If Highmark’s Financial Investigations and Provider Review (FIPR) identifies an overpayment, recovery of the overpayment is subject to each service region’s respective retroactive denial or overpayment collection laws as applicable.
Under the Ethics and Fairness in Insurance Business Practices Act, W.Va. Code § 33-45-1 et seq. (the “Prompt Pay Act”), Highmark West Virginia may retroactively deny an entire previously paid claim insured by Highmark West Virginia for a period of one year from the date the claim was originally paid. See also Chapter 6.1: General Claim Submission Guidelines for additional information about the Prompt Pay Act.
The Prompt Pay Act does not apply:
Under the Prompt Pay Act, upon receipt of a retroactive denial, the provider has 40 days to either: (1) notify Highmark West Virginia of the provider’s intent to reimburse the plan; or (2) request a written explanation of the reason for the denial.
Upon receipt of an explanation, a provider must: (1) reimburse Highmark West Virginia within 30 days; or (2) provide written notice that the provider disputes the denial. The provider should state reasons for disputing the denial and include any supporting information or documentation. Highmark West Virginia will review as an appeal and notify the provider of its final decision within 30 days after receipt of the provider’s notice of dispute. Please see the section titled Post-Payment Dispute Resolution Process – Appeals & External Review.
If the retroactive denial is upheld, the provider must pay the amount due within 30 days or the amount will be offset against future payments unless the provider notifies Highmark West Virginia in writing that the provider is disputing the review findings. The dispute resolution process shall be in accordance with the procedures outlined in this unit for West Virginia providers or, if there is a conflict, in accordance with the terms of the applicable provider agreement.
For overpayments and refunds not initiated by FIPR, see the section on “Overpayments and Refunds” in the manual’s Chapter 6.7: Payment/EOBs/Remittances.
The Retroactive Denial of Reimbursement Act, 40 Pa. C.S. § 3801 et seq. (the “Retroactive Denial Act”), prohibits the retroactive denial of a reimbursement to a health care provider (hereinafter “provider”) as a result of an overpayment determination more than 24 months after the date the insurer initially paid the provider. The Retroactive Denial Act does not apply:
Note: If Highmark submits a written request for medical or billing records to the provider, the provider has up to 60 days to provide the requested records, and the period of time for which it takes the provider to collect the requested records shall be added to the 24 month period.
Under the Retroactive Denial Act, if Highmark retroactively denies reimbursement to a provider, Highmark shall give the provider a written statement specifying the basis for the retroactive denial. If the provider disputes the retroactive denial, the provider shall notify Highmark in writing that the provider is disputing the findings. The dispute resolution process shall be in accordance with the procedures outlined in this unit for Pennsylvania providers or, if there is a conflict, in accordance with the terms of the applicable provider agreement.
For overpayments and refunds not initiated by FIPR, see the section on “Overpayments and Refunds” in the manual’s Chapter 6.7: Payment/EOBs/Remittances.
Title 18, Chapter 27 of the Delaware Code, 18 Del. C. § 2730 (the “Collection Overpayment Act”), prohibits the initiation of collection of overpayments from a health care provider (hereinafter “provider”) by a health insurer or health plan more than 24 months after the original payment for the claim was made. The Collection Overpayment Act does not apply:
Under the Collection Overpayment Act, if Highmark Delaware seeks to collect an overpayment, the provider shall be given written notice identifying the error and providing justification for the overpayment recovery. If the provider disputes the overpayment, the provider shall notify Highmark Delaware in writing that the provider is disputing the findings. The dispute resolution process shall be in accordance with the procedures outlined in this unit for Delaware providers or, if there is a conflict, in accordance with the terms of the applicable provider agreement. During the dispute resolution process, the provider will be entitled to any relevant claims information pursuant to the Collection Overpayment Act.
For overpayments and refunds not initiated by FIPR, see the section on “Overpayments and Refunds” in the manual’s Chapter 6.7: Payment/EOBs/Remittances.
New York State Insurance Law § 3224-b states a health plan shall not initiate overpayment recovery efforts more than 24 months after the original payment was received by a health care provider. However, no such time limit shall apply to overpayment recovery efforts that are:
For overpayment to healthcare providers — other than recovery for duplicate payments — Highmark New York shall provide 30 days written notice to health care providers before engaging in additional overpayment recovery efforts seeking recovery of the overpayment of claims to such health care providers.
Such notice shall state the patient’s name, service date, payment amount, proposed adjustment, and a reasonably specific explanation of the proposed adjustment. Highmark New York shall provide a health care provider with the opportunity to challenge an overpayment recovery, including the sharing of claims information, and shall establish written policies and procedures for health care providers to follow to challenge an overpayment recovery. Such a challenge shall set forth the specific grounds on which the provider is challenging the overpayment recovery.
For overpayments and refunds not initiated by FIPR, see the section on “Overpayments and Refunds” in the manual’s Chapter 6.7: Payment/EOBs/Remittances.
The post-payment review dispute resolution process is intended to address a multitude of disputes and provides a means whereby Highmark and the provider will resolve any disputes related to claims for services submitted to Highmark.
Any provider that treats a Highmark member has the right to dispute claims payment decisions made by Highmark. It is important to note that the dispute will be governed by the terms of the provider’s contract with Highmark and not under the plan through which a member receives benefits. A provider’s request for payment of services will be made directly to Highmark rather than the plan providing the member’s benefits. This includes plans governed by either the Employee Retirement Income Security Act of 1974 (ERISA) or the Patient Protection and Affordable Care Act of 2010 (PPACA). Therefore, any claim dispute between a provider and Highmark arising from a provider’s request for payment is solely a contract dispute between the provider and Highmark, and does not involve any other party.
In addition, benefit plans and plan sponsors are not parties to any contracts with providers. Providers are bound to the terms of their respective contracts with Highmark. Such provider contracts are not binding upon any benefit plan or plan sponsor.
A post-payment review dispute is a dispute that arises as a result of one or more claims reviews conducted by Highmark and/or its designated agents. Post-payment review disputes include, but are not limited to, coding disputes.
A coding dispute shall mean a dispute that arises as a result of one or more claims coding reviews as conducted by Highmark and/or its designated agent and that: (a) result in a disagreement as to the appropriate code(s) assigned to a particular diagnosis and/or service rendered or supplied by Provider to a Member; and (b) has not been resolved by the parties through informal means.
Disputes regarding benefit coverage are not claim review disputes.
All Highmark insurance policies for members contain anti-assignment provisions. As a result, a provider cannot dispute a claim with benefit plans or plan sponsors in the event a member’s benefits are denied in whole or in part unless the provider follows the appropriate steps to be the member’s authorized representative for purposes of a member appeal. An assignment of benefits form is not enough, is not valid under member policies, and will not be recognized by Highmark. In addition, member appeals are separate and apart from the claim review dispute process outlined in this unit.
If providers disagree with the review findings, they have the opportunity to appeal the findings to Highmark and may also have external review options.
Please refer to the region-specific sections below for additional information for consideration as well as the section titled Retroactive Denials and Overpayments.
Professional health service doctors, as defined in 40 Pa. C.S.A. § 6302, in Pennsylvania may have the right to appeal their case to the Medical Review Committee (MRC). Determinations made by the MRC are binding on both the health service doctor and Highmark. For additional information, please refer to the Highmark Medical Review Committee (PA Only) section of this unit.
The appeal rights of facility providers in Pennsylvania vary based on the type of review that was conducted:
The appeal rights of professional providers in Delaware vary based on the type of review that was conducted:
If professional providers in Delaware are not satisfied with Highmark Delaware’s final appeal decision, they have a right to appeal their case to the Delaware Department of Insurance. Determinations made by the Delaware Department of Insurance are binding on both the provider and Highmark Delaware, except the losing party in such an arbitration shall have a right to trial de novo in the Delaware Superior Court so long as notice of appeal is filed with that Court in the manner set forth by Superior Court rules within 30 days of the date of the arbitration decision being rendered. For additional information, please refer to the Delaware Department of Insurance (DE Only) section of this unit.
The appeal rights of facility providers in Delaware vary based on the type of review that was conducted:
If facility providers in Delaware are not satisfied with the final appeal decision, they have a right to appeal their case to the Delaware Department of Insurance. Determinations made by the Delaware Department of Insurance are binding on both the facility provider and Highmark Delaware except the losing party in such an arbitration shall have a right to trial de novo in the Delaware Superior Court so long as notice of appeal is filed with that Court in the manner set forth by Superior Court rules within 30 days of the date of the arbitration decision being rendered. For additional information, please refer to the Delaware Department of Insurance (DE Only) section of this unit.
Professional Providers:
Professional providers who do not agree with FIPR review findings must request an appeal within the time frame stated in the Notice of Review Results Letter. Following review of the appeal, the provider will receive a determination letter explaining the findings.
If professional providers in West Virginia are not satisfied with the appeal determination, they may have the right to request review by an Independent Review Organization (IRO). Determinations made by the IRO are binding on both the provider and Highmark West Virginia. For additional information, please refer to the Independent Review Organization (IRO) section of this unit. All available review options are subject to the terms of the Provider/Network Agreement.
Facility Providers:
Facility providers that do not agree with the review findings must request an appeal within the time frame stated in the Review Findings Letter. Following review of the appeal, the provider will receive a determination letter explaining the findings.
If facility providers in West Virginia are not satisfied with the appeal determination, additional review options vary based the type of review that was conducted:
All available review options are subject to the terms of the Provider/Network Agreement.
Professional Providers:
If a professional provider in New York is not satisfied with the appeal determination, the practitioner may have the right to request review by an independent review organization (IRO). Determinations made by the IRO are binding on both the provider and Highmark New York. For additional information, please refer to the Independent Review Organization (IRO) section of this unit. All available review options are subject to the terms of the Provider/Network Agreement.
Once the parties have exhausted, all attempts to resolve the dispute, including non-binding mediation, the parties can submit the dispute to binding arbitration with the American Health Lawyers Association (AHLA) for a final determination.
The arbitration shall be held at a location in Buffalo or Albany, New York, to be mutually agreed upon by the parties and conducted pursuant to the Rules of Procedure for Arbitration of the AHLA, Alternative Dispute Resolution Service. Unless otherwise agreed upon by the parties in writing, the dispute shall be determined by a panel of three arbitrators who are members of the AHLA, are current members of the AHLA panel of Dispute Resolvers, and are attorneys who are familiar with issues relating to payment for hospital services by health care plans. Each party shall appoint one arbitrator and the third shall be mutually selected by the two arbitrators appointed by the parties.
Facility Providers:
Facility providers who do not agree with the review findings must request an appeal within the time frame stated in the Review Findings Letter. Following review of the appeal, the provider will receive a determination letter explaining the findings.
If a facility provider in New York is not satisfied with the appeal determination, the facility provider may request Mediation or Arbitration in accordance with the terms of the provider’s contract with Highmark Blue Cross Blue Shield/Highmark Blue Shield.
When a provider disputes a coding decision made by Highmark or its designated agent, the provider and Highmark shall make a good faith effort to resolve the dispute by first exhausting available appeal options and shall discuss the matter with the appropriate representative(s).
Subject to the applicable Provider/Network Agreement, following exhaustion of available appeal option(s), if the provider remains in disagreement with the findings, the provider may request review by an Independent Review Organization (IRO), which may be referred to as a certified review entity (“CRE”), to perform a review and conclusively resolve the dispute.
The provider must state its intention to either accept Highmark’s or its designee’s findings or request review by an IRO within the time period as set forth in written correspondence, i.e., the Appeal Determination Letter. The letter will also include a list of two IRO entities from which the provider must choose. All listed IROs shall be independent entities from Highmark (other than with respect to any contract with Highmark to provide IRO services).
If the provider fails to timely respond with its intention to appeal and its selection of an IRO from the list, then the parties agree that the provider shall be deemed to have accepted the decision made by Highmark or its designee, and Highmark will initiate repayment efforts up to and including performing automatic offset against future payments to recoup the stated overpayment.
The resolution process set forth herein is the sole means for resolving coding disputes.
For providers in Pennsylvania, in instances where an agreement between the provider and Highmark states that the decision by the IRO shall be final and binding on, and non-appealable by, Highmark and the provider/business owner, each party waives its right to commence litigation as to the coding review dispute in a court of law as well as appeal the determination by the IRO of a coding review dispute to a court of law.
For providers in West Virginia, the decision of the IRO shall be final and binding on Highmark and the provider/business owner.
For providers where a contractual agreement or a letter of agreement is in place regarding the use of an IRO, when the IRO’s decision is fully in favor of one party, the other party shall pay the entire fees and costs associated with the IRO’s review and decision. If the IRO’s decision is partly in favor of each party, the parties shall share equally the cost of the review. If required by the IRO, Highmark and the provider shall make escrow deposits to cover the costs of the review by the IRO.
For West Virginia providers, when the IRO’s decision is fully in favor of one party, the other party shall pay the entire fees and costs associated with the IRO’s review and decision. If the IRO’s decision is partly in favor of each party, the parties shall share equally the cost of the review. If required by the IRO, Highmark and the provider shall make escrow deposits to cover the costs of the review by the IRO.
All disputes not resolved by negotiation as described in this section of this unit must be submitted to an IRO within the time period provided by the applicable limitation of time for bringing such action or proceeding as contained in the network agreement, hospital agreement, or, where applicable, federal or state law.
In Pennsylvania, any claims review dispute involving claims submitted by a health service doctor that remains unresolved may be referred to the Medical Review Committee (MRC) for consideration as required by law or the health service doctor’s contract with Highmark.
The MRC is charged with hearing matters, disputes, or controversies relating to the professional health services rendered by health service doctors, or any questions involving professional ethics.
The Medical Review Committee (MRC) is made up predominantly of health care professionals and is established pursuant to the Bylaws of Highmark Inc. The Medical Review Committee investigates and resolves claim disputes arising out of the relationship between the Corporation and professional health care providers in Pennsylvania who render health services to Highmark members; certain restrictions apply. The committee’s decisions are based on current medical practices and Highmark Medical Policy.
In addition, appeals of credentialing decisions are directed to the Medical Review Committee. In the event of an appeal, the Highmark Medical Review Committee is available, upon written request, to any professional network practitioner who has been notified of termination or a denial decision. The Medical Review Committee’s decision is final and not subject to further appeal.
The Medical Review Committee consists of at least eight members. A majority of the members of the Medical Review Committee are providers who are participating providers, preferred providers, or network providers (“provider members”). The balance are consumers covered under health care contracts issued by the Corporation (“consumer members”).
At least two-thirds of the members of the Medical Review Committee shall have no relationship with Highmark (other than as providers who submit claims in the ordinary course of business or members covered by one of Highmark’s health care programs). No member shall be a member of the Board of Directors of Highmark.
The provider members of the Medical Review Committee are representative of the various health care professions and specialties whose services are covered by Highmark. At least three-fourths of the provider members of the Highmark Medical Review Committee must be medical doctors or doctors of osteopathy.
No member of the Medical Review Committee who has any conflict of interest that would prevent him or her from rendering a fair and impartial decision or is in economic competition with a provider shall participate in the decision-making process with respect to such practitioner.
Determinations made by Highmark’s Medical Review Committee (MRC) are based on current medical practice, Highmark Medical Policy, and Highmark credentialing policy. If you choose the MRC, its decision is considered your final level of internal appeal. You will be notified of the MRC decision in writing.
The committee is made up of a variety of degree specialties and lay members. The Review Committee Selection Committee is responsible for appointing MRC members. As per the Bylaws of Highmark Inc., the Medical Review Committee is charged with the following responsibilities:
After all other appeals with Highmark are exhausted, providers in Pennsylvania may submit a matter for review to the Medical Review Committee in writing to:
Secretary, Medical Review Committee (MRC)
Financial Investigations & Provider Review
Highmark Inc.
1800 Center Street
CH1BHM-041B
Camp Hill, PA 17011
The Highmark Blue Shield Review Committee Guidelines are available in the Appendix of the Highmark Provider Manual (in Pennsylvania only).
You can access the Appendix from the Additional Resources box at the bottom of the manual home page.
In Delaware, any provider review conducted by Financial Investigations and Provider Review (FIPR) staff that remains unresolved can be referred to the Delaware Department of Insurance (DOI) for consideration.
If a provider is not satisfied with a Highmark Delaware final appeal decision regarding reimbursement, the provider may have a right to arbitration.
If the provider is a provider as defined by 18 Del. C. §333(a)(1), the provider has the right to seek review of Highmark Delaware’s decision regarding the final disposition of a claim(s). The Delaware Department of Insurance provides claim arbitration services, which are in addition to, but do not replace, any other legal or equitable right the provider may have to review this decision or any right of review based on the provider’s contract with Highmark Delaware.
The provider may contact the Delaware Department of Insurance for information about arbitration by calling the Arbitration Secretary at 302-674-7322. The provider may also go to the Delaware Insurance Department to personally discuss the arbitration process between the hours of 8:30 a.m. and 4:00 p.m. at the following location:
The Rodney Building
841 Silver Lake Blvd.
Dover, DE 19904
All requests for arbitration must be filed within 60 days from the date the provider receives the adverse determination from Highmark Delaware; otherwise, the Highmark Delaware decision will be final.
The following entities, which serve the noted regions, are independent licensees of the Blue Cross Blue Shield Association: Western and Northeastern PA: Highmark Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Choice Company, Highmark Health Insurance Company, Highmark Coverage Advantage Inc., Highmark Benefits Group Inc., First Priority Health, First Priority Life or Highmark Senior Health Company. Central and Southeastern PA: Highmark Inc. d/b/a Highmark Blue Shield, Highmark Benefits Group Inc., Highmark Health Insurance Company, Highmark Choice Company or Highmark Senior Health Company. Delaware: Highmark BCBSD Inc. d/b/a Highmark Blue Cross Blue Shield. West Virginia: Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Health Insurance Company or Highmark Senior Solutions Company. Western NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Cross Blue Shield. Northeastern NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Shield.
All references to “Highmark” in this document are references to the Highmark company that is providing the member’s health benefits or health benefit administration and/or to one or more of its affiliated Blue companies.
All revisions to this Highmark Provider Manual (the “manual” or “Highmark Provider Manual”) are controlled electronically. All paper copies and screen prints are considered uncontrolled and should not be relied upon for any purpose.